Wealthspire Advisors, LLC Cardiol Therapeutics Inc. Transaction History
Wealthspire Advisors, LLC
- $16.6 Billion
- Q1 2025
A detailed history of Wealthspire Advisors, LLC transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Wealthspire Advisors, LLC holds 15,151 shares of CRDL stock, worth $20,150. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,151
Previous 15,151
-0.0%
Holding current value
$20,150
Previous $19,000
26.32%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CRDL
# of Institutions
42Shares Held
7.81MCall Options Held
25.9KPut Options Held
1.7K-
Tejara Capital LTD London, X03.19MShares$4.25 Million1.2% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD982KShares$1.31 Million0.19% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9783KShares$1.04 Million0.35% of portfolio
-
Ubs Group Ag498KShares$662,1490.0% of portfolio
-
Pvg Asset Management Corp Golden, CO437KShares$581,6911.99% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $82.4M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...